Press Release Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that its Trials in Progress abstract has been ...

The Symposium of Student Research and Creative Activity was a daylong event for motivated students on April 24 to showcase research projects to guests, staff and other students through a poster-board ...

Meaningful and durable increases in functional neutrophils observed over 6-month trial with oral once-daily mavorixafor. Majority of physicians and chronic neutropenia participant ...

Our latest posters, at the world's most prestigious gene therapy event, provide critical insights into the safety and efficacy of rAAV-based therapeutics. We support biopharma companies with ...

UW-Stout's Research Day showcases innovative student projects, including heavy metals in everyday products and solutions to ...

Greetings and welcome to the PDS Biotech first quarter in 2025 earnings conference call. (operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce ...

Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is ...

Presentations will be available on the Alterity Therapeutics website here.

ALPENA — Teamwork took center stage on Saturday — not on the field, but in the water — as student teams competed in the 2025 MATE Great Lakes Regional ROV Competition at the Great Lakes Maritime ...

A First-in-Class Hydrolysis-Activated Liver-Targeted THR-ß Prodrug Demonstrating A Dual Advantage of Fat Reduction and Muscle Preservation SHANGHAI, May 16, 2025 /PRNewswire/ -- At the European ...

Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet ...